TickerFacts.

Idexx Laboratories Inc (IDXX): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.64B
Year ended 2025-12-31
$1.71B
Trailing 12 months to 2026-06-30
+6.5%
3-year compound annual growth
+7.7%
5-year compound annual growth
+8.7%
10-year compound annual growth
2008-12-31: $494.26M2009-12-31: $505.35M2010-12-31: $524.77M2011-12-31: $572.18M2012-12-31: $594.19M2013-12-31: $620.94M2014-12-31: $669.69M2015-12-31: $711.62M2016-12-31: $799.99M2017-12-31: $871.68M2018-12-31: $971.70M2019-12-31: $1.04B2020-12-31: $1.14B2021-12-31: $1.33B2022-12-31: $1.36B2023-12-31: $1.47B2024-12-31: $1.52B2025-12-31: $1.64B$1.64B
2008-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$1.64B+8.3%2026-02-20, From 2025-01-01
2024-12-31$1.52B+3.2%2026-02-20, From 2024-01-01
2023-12-31$1.47B+7.9%2026-02-20, From 2023-01-01
2022-12-31$1.36B+2.8%2025-02-21, From 2022-01-01
2021-12-31$1.33B+16.8%2024-02-22, From 2021-01-01
2020-12-31$1.14B+9.1%2023-02-16, From 2020-01-01
2019-12-31$1.04B+7.2%2022-02-16, From 2019-01-01
2018-12-31$971.70M+11.5%2021-02-12, From 2018-01-01
2017-12-31$871.68M+9.0%2020-02-14, From 2017-01-01
2016-12-31$799.99M+12.4%2019-02-15, From 2016-01-01
2015-12-31$711.62M+6.3%2018-02-16, From 2015-01-01
2014-12-31$669.69M+7.9%2017-02-17, From 2014-01-01
2013-12-31$620.94M+4.5%2016-02-17, From 2013-01-01
2012-12-31$594.19M+3.8%2015-02-17, From 2012-01-01
2011-12-31$572.18M+9.0%2014-02-18, From 2011-01-01
2010-12-31$524.77M+3.8%2013-02-19, From 2010-01-01
2009-12-31$505.35M+2.2%2012-02-17, From 2009-01-01
2008-12-31$494.26Mn/a2011-02-22, From 2008-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$1.64B+8.3%
Lantheus Holdings, Inc. (LNTH)2025-12-31$599.66M+9.9%
Neogen Corp (NEOG)2026-05-31$461.90M-2.4%
Myriad Genetics Inc (MYGN)2025-12-31$247.90M-1.7%
Alpha Teknova, Inc. (TKNO)2025-12-31$27.08M-11.3%
Immucell Corp (ICCC)2025-12-31$16.20M-12.7%
Aspira Women's Health Inc. (AWHL)2025-12-31$3.30M-10.9%
Anbio Biotechnology (NNNN)2025-12-31$1.10M-52.0%
Biomerica Inc (BMRA)2026-05-31$4.09M-15.0%

Compare IDXX, LNTH, NEOG, MYGN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗